Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Sep 18, 2022; 12(9): 281-287
Published online Sep 18, 2022. doi: 10.5500/wjt.v12.i9.281
Published online Sep 18, 2022. doi: 10.5500/wjt.v12.i9.281
Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
Maria Styliani Kalogirou, Olga Giouleme, Gastroenterology and Hepatology Division of the Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki 54642, Greece
Author contributions: Kalogirou M wrote the paper; Giouleme O critically revised it for important intellectual content.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Maria Styliani Kalogirou, MD, MSc, Doctor, Research Fellow, Gastroenterology and Hepatology Division of the Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Medical School, Aristotle University of Thessaloniki, Konstantinoupoleos 49, Thessaloniki 54642, Greece. maria.kalogi32@gmail.com
Received: June 10, 2022
Peer-review started: June 10, 2022
First decision: July 12, 2022
Revised: July 19, 2022
Accepted: August 12, 2022
Article in press: August 12, 2022
Published online: September 18, 2022
Peer-review started: June 10, 2022
First decision: July 12, 2022
Revised: July 19, 2022
Accepted: August 12, 2022
Article in press: August 12, 2022
Published online: September 18, 2022
Core Tip
Core Tip: Non-alcoholic fatty liver disease (NAFLD) is a common complication in liver transplant recipients. Despite the rising prevalence and potentially progressive nature of this entity, there are currently no recommendations regarding NAFLD diagnosis and management in the post-transplant setting. Future studies are urgently needed to fill this knowledge gap and define optimal diagnostic and treatment approaches in this patient population.